Viewing Study NCT01796535


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-25 @ 8:12 PM
Study NCT ID: NCT01796535
Status: UNKNOWN
Last Update Posted: 2013-03-15
First Post: 2012-12-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The PerX360º System™ Registry
Sponsor: Interventional Spine, Inc.
Organization:

Study Overview

Official Title: An Observational, Multi Center, Non-Randomized (Single Arm) Registration of the PerX360º System™
Status: UNKNOWN
Status Verified Date: 2013-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OptiLIF™
Brief Summary: This is a multi-center, non-randomized post marketing surveillance registry including up to 125 patients treated with the PerX360º System™. Patients will receive a follow-up evaluation at the per physician defined time points: at discharge, an Interim 1 visit (1 month), an Interim 2 visit (3-6 months) and a Final visit (12 months). Imaging obtained at visits should be per standard of care.
Detailed Description: For all patients participating in the registry, the following outcomes will be analyzed:

* Change in pain score on the Visual Analog Scale(VAS) from baseline for leg pain
* Change in pain score on the Visual Analog Scale(VAS) from baseline for back pain
* Change in Oswestry Disability Index (ODI) score from baseline
* Proportion of patients with a device related complication
* Proportion of patients with lack of revision, removal, or reoperation
* Proportion of patients with radiographic fusion

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: